The global hematologic malignancies market size reached US$ 60.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 122.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. Growing prevalence of blood cancer, increasing adoption of targeted therapies and immunotherapies tailored to genetic profiles, and expansion of biopharmaceutical ... https://www.imarcgroup.com/eye-testing-equipment-market